Abvc Biopharma Inc Reports Results For The Quarter Ended In December: Earnings Summary

ABVC Biopharma

03/04/2023 22:02

* ABVC Biopharma Inc  ABVC.OQ  reported a quarterly adjusted
loss
of 15 cents​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 1,650% to $589.00 thousand from a year ago;
analysts expected $13.00 thousand. 
    * ABVC Biopharma Inc's reported EPS for the quarter was a
loss
of 15 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * ABVC Biopharma Inc shares had held steady so far this
quarter and gained 2.4% so far this year.
    * The company reported a quarterly loss of $4.5 million.
    * Wall Street's median 12-month price target for ABVC
Biopharma
Inc is $2.02 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 3 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.15          -0.15          Met
 Sep. 30 2022      -0.12          -0.11          Beat
 Jun. 30 2022      -0.12          -0.06          Beat
                                  -0.20